Ceramide and N,N,N-Trimethylphytosphingosine-Iodide (TMP-I)-Based Lipid Nanoparticles for Cancer Therapy

Pharmaceutical Research
Prabagar BalakrishnanHyun-Jong Cho

Abstract

To evaluate the anti-tumor effect of ceramide or trimethylphytosphingosine-iodide (TMP-I) containing solid lipid nanoparticles (SLNs) prepared using trymyristin, phosphatidylcholine (PC), and Pluronic P85 (P85) for intravenous delivery of docetaxel. Docetaxel-loaded SLNs using ceramide or TMP-I at 3.22% (w/w) with a mean diameter of 89-137 nm were successfully prepared by high pressure homogenization. The prepared nanoparticles were characterized by particle size, zeta potential, drug content, and TEM analysis. Cellular uptake and cytotoxicity were studied using adriamycin-resistant breast cancer (MCF-7/ADR) cells. The optimized formulation's dissolution profile, pharmacokinetics, and antitumor effect in mice tumor model were compared with that of control (Taxotere(®)). The drug release rate of docetaxel from SLNs was lower than that of control (Taxotere(®)). The prepared SLNs showed higher cellular uptake of docetaxel compared to that of Taxotere(®) in MCF-7/ADR cell lines, which was further confirmed by the confocal laser scanning microscopy (CLSM) study using coumarin 6 (C6). Prepared SLNs exhibited significantly increased antitumor efficacy, compared to Taxotere(®), in MCF-7/ADR cells. In vivo pharmacokinetic study in rats ...Continue Reading

References

Aug 15, 1998·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·A zur MühlenW Mehnert
May 20, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·S C YangC Z Yang
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R H MüllerS Gohla
Apr 20, 2001·Advanced Drug Delivery Reviews·W Mehnert, K Mäder
May 16, 2002·The Journal of Biological Chemistry·Sarah Spiegel, Sheldon Milstien
Aug 23, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Maria Laura ImmordinoLuigi Cattel
May 26, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elke PersohnGuido Cavaletti
Jul 6, 2005·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Torsten M Göppert, Rainer H Müller
Aug 19, 2006·IUBMB Life·Joanna Woodcock
May 29, 2007·Advanced Drug Delivery Reviews·Ho Lun WongXiao Yu Wu
Sep 27, 2007·Pharmaceutical Research·Martin Werle
May 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Harikrishna DevalapallyMansoor M Amiji
Oct 30, 2008·Current Opinion in Lipidology·Jannick Pétremand, Christian Widmann
Feb 10, 2009·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Jackie BakerGunter von Minckwitz
Aug 28, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yong-Mei YinDae-Duk Kim
Aug 24, 2010·International Journal of Pharmaceutics·Yi-Dong YanHan Gon Choi

❮ Previous
Next ❯

Citations

Dec 17, 2019·Prostaglandins & Other Lipid Mediators·Jianzhong ChenZhijun Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.